Evidence map›Paper›PMID 31460362›Full record

ArticleACS omega2019

Huiqiang Li, Xiaohui Zhang, Hsuan Yi Wu, Lingyi Sun, Yongyong Ma, Junling Xu, Qing Lin, Dexing Zeng

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in ACS omega, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.4field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 10 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 2 countries.

Huiqiang LiPET-CT Center, Department of Nuclear Medicine, Henan Provincial People's Hospital, Weiwu Road, No. 7, Jinshui District, Zhengzhou, Henan CN 450003, China.
Xiaohui ZhangMolecular Imaging Laboratory, Department of Medicine, University of Pittsburgh, 3501 Fifth Avenue, Pittsburgh, Pennsylvania 15219, United States.
Hsuan Yi WuDepartment of Chemistry, State University of New York at Buffalo, 679 Natural Sciences Complex, Buffalo, New York 14260, United States.
Lingyi SunMolecular Imaging Laboratory, Department of Medicine, University of Pittsburgh, 3501 Fifth Avenue, Pittsburgh, Pennsylvania 15219, United States.
Yongyong MaMolecular Imaging Laboratory, Department of Medicine, University of Pittsburgh, 3501 Fifth Avenue, Pittsburgh, Pennsylvania 15219, United States.
Junling XuPET-CT Center, Department of Nuclear Medicine, Henan Provincial People's Hospital, Weiwu Road, No. 7, Jinshui District, Zhengzhou, Henan CN 450003, China.
Qing LinDepartment of Chemistry, State University of New York at Buffalo, 679 Natural Sciences Complex, Buffalo, New York 14260, United States.
Dexing ZengMolecular Imaging Laboratory, Department of Medicine, University of Pittsburgh, 3501 Fifth Avenue, Pittsburgh, Pennsylvania 15219, United States.
Oregon Health & Science University · USUniversity at Buffalo, State University of New York · USUniversity of Pittsburgh · USHenan Provincial People's Hospital · CN

Funding

VECTOR CORE FACILITYP30CA047904 · NCI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI Jessie Nedrow · 1988 to 2026
$158.0M
Novel Platform to achieve high avidity of heterodimers for targeted cancer imagingR21EB020737 · NIBIB · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI ZENG, DEXING · 2015 to 2016
$424k
NCI NIH HHS P30 CA047904NIBIB NIH HHS R21 EB020737
6 · The paper itself

Abstract

Ubiquitin has been recently identified as a chemokine receptor 4 (CXCR4) natural ligand, offering great potential for positron emission computed tomography (PET) imaging of CXCR4 expression. This study reports the preparation and evaluation of (

Identifiers

PMID31460362
PMCPMC6682141
OpenAlexW2964013251

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.